Scimex: An Australian-led study has described a new drug that can block
inflammation without any of the usual adverse side effects, such as high
cholesterol, high blood fats and weight gain, observed with other
anti-inflammatory drugs. The researchers say that the drug is now in
phase two clinical trials for people with Rheumatoid Arthritis and shows
promise in treating many people with inflammatory conditions.